The week of 2026-02-17, 28 holders filed a new Schedule 13D and 403 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-02-20 | Sotherly Hotels Inc. | KW Kingfisher LLC | 100% | SCHEDULE 13D |
| 2026-02-18 | Evolution Metals & Technologies Corp. | The Zeus Trust, UA dated April 15, 2025 | 70.18% | SCHEDULE 13D |
| 2026-02-17 | Docebo Inc. | Jason Chapnik | 56.7% | SCHEDULE 13D |
| 2026-02-17 | M2i Global, Inc. | Executive Real Estate LLC | 45.25% | SCHEDULE 13D |
| 2026-02-19 | United Acquisition Corp. I | United Acquisition SPAC LLC | 27.3% | SCHEDULE 13D |
| 2026-02-18 | Space Asset Acquisition Corp. | Space Asset Acquisition Sponsor LLC | 25.48% | SCHEDULE 13D |
| 2026-02-20 | Columbus Circle Capital Corp II | Columbus Circle 2 Sponsor Corporation LLC | 25.3% | SCHEDULE 13D |
| 2026-02-18 | Boxlight Corp | Khan MD Ehsan | 24.3% | SCHEDULE 13D |
| 2026-02-17 | Spyglass Pharma, Inc. | RA Capital Management, L.P. | 24.1% | SCHEDULE 13D |
| 2026-02-20 | DNA X, Inc. | DNA Holdings Venture Inc. | 19.9% | SCHEDULE 13D |
| 2026-02-17 | Investcorp Europe Acquisition Corp I | Meteora Capital, LLC | 18.78% | SCHEDULE 13D |
| 2026-02-17 | Agomab Therapeutics NV | LSP 7 Cooperatieve U.A. | 10.6% | SCHEDULE 13D |
| 2026-02-20 | Immunic, Inc. | Biotechnology Value Fund L P | 9.99% | SCHEDULE 13D |
| 2026-02-19 | Funko, Inc. | Fund 1 Investments, LLC | 9.96% | SCHEDULE 13D |
| 2026-02-18 | Infleqtion, Inc. | Maverick Capital, Ltd. | 9.2% | SCHEDULE 13D |
| 2026-02-19 | Phreesia, Inc. | Pale Fire Capital SE | 9.2% | SCHEDULE 13D |
| 2026-02-18 | Angi Inc. | Pale Fire Capital SE | 8.3% | SCHEDULE 13D |
| 2026-02-19 | SCI Engineered Materials, Inc. | Charles Kohnen | 8.12% | SCHEDULE 13D |
| 2026-02-18 | Innventure, Inc. | Ascent Capital Partners LLC | 6.7% | SCHEDULE 13D |
| 2026-02-18 | Scholastic Corporation | Iole Lucchese | 5.5% | SCHEDULE 13D |
| 2026-02-17 | Innventure, Inc. | Commonwealth Asset Management LP | 5.3% | SCHEDULE 13D |
| 2026-02-17 | Radcom Ltd | Value Base Ltd. | 5.27% | SCHEDULE 13D |
| 2026-02-18 | Natural Health Trends Corp | Sharng Chris Tahjiun | 5.2% | SCHEDULE 13D |
| 2026-02-20 | Huntsman CORP | Peter R. Huntsman | 5.09% | SCHEDULE 13D |
| 2026-02-20 | enVVeno Medical Corp | Northstrive Fund II LP | 5.05% | SCHEDULE 13D |
| 2026-02-20 | enVVeno Medical Corp | Braeden Lichti | 5.05% | SCHEDULE 13D |
| 2026-02-18 | Urban Outfitters Inc | David A. Hayne | 5.04% | SCHEDULE 13D |
| 2026-02-18 | GSI Technology, Inc. | Galloway Capital Partners, LLC | 5.02% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-02-18 | Partners Group Lending Fund, LLC | Australian Retirement Trust Pty Ltd | 90.91% | SCHEDULE 13G |
| 2026-02-17 | TGE Value Creative Solutions Corp. | TGE SpiderNet Capital Group LLC | 87.5% | SCHEDULE 13G |
| 2026-02-17 | Crestline Lending Solutions, LLC | Partners Capital Holdings, LLP | 85% | SCHEDULE 13G |
| 2026-02-17 | The Generation Essentials Group | AMTD Group Inc. | 77.9% | SCHEDULE 13G |
| 2026-02-17 | Range Acquisition Corp. | Mark N. Tompkins | 75% | SCHEDULE 13G |
| 2026-02-17 | Primus Acquisition Inc. | Mark N. Tompkins | 75% | SCHEDULE 13G |
| 2026-02-17 | Fast Track Group | Lim Sin Foo, Harris | 53.15% | SCHEDULE 13G |
| 2026-02-17 | Cardinal Infrastructure Group Inc | Jeremy Simmons Spivey | 45% | SCHEDULE 13G |
| 2026-02-17 | BGIN BLOCKCHAIN Ltd | Qiuhua Li | 41.93% | SCHEDULE 13G |
| 2026-02-17 | JM Group Ltd | Chun Kwok Stanley Ting | 41.3% | SCHEDULE 13G |
| 2026-02-17 | Cardinal Infrastructure Group Inc | Michael Bruce Rowe, Jr. | 29% | SCHEDULE 13G |
| 2026-02-17 | Cardinal Infrastructure Group Inc | Erik Daniel West | 29% | SCHEDULE 13G |
| 2026-02-17 | Copley Acquisition Corp | Copley Acquisition Sponsors, LLC | 26.57% | SCHEDULE 13G |
| 2026-02-17 | New America Acquisition I Corp. | New America Sponsor I LLC | 26.31% | SCHEDULE 13G |
| 2026-02-17 | Vine Hill Capital Investment Corp. II | Vine Hill Capital Sponsor II LLC | 25% | SCHEDULE 13G |
| 2026-02-17 | Range Acquisition Corp. | Ian Jacobs | 25% | SCHEDULE 13G |
| 2026-02-17 | Primus Acquisition Inc. | Ian Jacobs | 25% | SCHEDULE 13G |
| 2026-02-18 | Galata Acquisition Corp. Ii | Galata Acquisition Sponsor II, LLC | 25% | SCHEDULE 13G |
| 2026-02-17 | Regentis Biomaterials Ltd. | Dr. Ehud Geller | 23.2% | SCHEDULE 13G |
| 2026-02-17 | Karbon Capital Partners Corp. | Karbon Capital Partners Core Holdings, LLC | 21.6% | SCHEDULE 13G |
| 2026-02-17 | BGIN BLOCKCHAIN Ltd | Qingfeng Wu | 20.16% | SCHEDULE 13G |
| 2026-02-17 | Liberty Live Holdings, Inc. | Warren E. Buffett | 19.5% | SCHEDULE 13G |
| 2026-02-18 | Ituran Location & Control Ltd | Izzy Sheratzky | 19.44% | SCHEDULE 13G |
| 2026-02-17 | Grupo Aeromexico, S.A.B. de C.V. | Apollo Management Holdings GP, LLC | 18.9% | SCHEDULE 13G |
| 2026-02-17 | Banzai International, Inc. | CP BF Lending, LLC | 18.7% | SCHEDULE 13G |
| 2026-02-19 | Meshflow Acquisition Corp | Meshflow Acquisition Sponsor LLC | 18.7% | SCHEDULE 13G |
| 2026-02-17 | MNTN, Inc. | Mark Douglas | 17.8% | SCHEDULE 13G |
| 2026-02-17 | Arcos Dorados Holdings Inc | Lazard Asset Management LLC | 16.4% | SCHEDULE 13G |
| 2026-02-17 | Korea Fund Inc | Lazard Asset Management LLC | 13.3% | SCHEDULE 13G |
| 2026-02-17 | Global Indemnity Group, LLC | Essex Equity Joint Investment Vehicle, LLC | 13.27% | SCHEDULE 13G |
| 2026-02-18 | Aurora Mobile Limited | PM Partners I LP | 13.2% | SCHEDULE 13G |
| 2026-02-17 | Navan, Inc. | Marc L. Andreessen | 11.7% | SCHEDULE 13G |
| 2026-02-17 | Elauwit Connection, Inc | Maxim Cerith LLC | 11.3% | SCHEDULE 13G |
| 2026-02-17 | Janus Detroit Street Trust | Hennion & Walsh Asset Management, Inc. | 11.3% | SCHEDULE 13G |
| 2026-02-17 | Wealthfront Corp | Tiger Global Private Investment Partners X, L.P. | 10.4% | SCHEDULE 13G |
| 2026-02-17 | Navan, Inc. | Lightspeed General Partner X, L.P. | 10.1% | SCHEDULE 13G |
| 2026-02-17 | Qt Imaging Holdings, Inc. | Alyeska Investment Group, L.P. | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Rekor Systems, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | SOBR Safe, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Virax Biolabs Group Limited | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | VSee Health, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Wearable Devices Ltd. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Edible Garden AG Inc | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Glucotrack, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | HCW Biologics Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Imunon, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Invo Fertility, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Aethlon Medical Inc | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Ascent Solar Technologies, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Biodexa Pharmaceuticals Plc | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Bluejay Diagnostics, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Cycurion, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Minerva Neurosciences, Inc. | Balyasny Asset Management L.P. | 9.99% | SCHEDULE 13G |
| 2026-02-17 | NextCure, Inc. | Ikarian Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Mdjm Ltd | Mitchell P. Kopin | 9.99% | SCHEDULE 13G |
| 2026-02-18 | Adial Pharmaceuticals, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-18 | Bluejay Diagnostics, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-19 | Iveda Solutions, Inc. | Lind Global Fund III LP | 9.99% | SCHEDULE 13G |
| 2026-02-19 | Our Bond, Inc. | Ascent Partners Fund LLC | 9.99% | SCHEDULE 13G |
| 2026-02-20 | Minerva Neurosciences, Inc. | Coastlands Capital LP | 9.99% | SCHEDULE 13G |
| 2026-02-20 | Immunic, Inc. | Vivo Opportunity Fund Holdings, L.P. | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Minerva Neurosciences, Inc. | Logos Global Management LP | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Adagio Medical Holdings, Inc. | Alyeska Investment Group, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Critical Metals Corp. | Alyeska Investment Group, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Dragonfly Energy Holdings Corp. | Alyeska Investment Group, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Brazil Potash Corp. | Alyeska Investment Group, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-17 | In8bio, Inc. | Alyeska Investment Group, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Velo3D, Inc. | Alyeska Investment Group, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Veru Inc. | Alyeska Investment Group, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Blue Water Acquisition Corp. III | Anson Funds Management LP | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Digital Currency X Technology Inc. | Anson Funds Management LP | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Kartoon Studios Inc | Anson Funds Management LP | 9.9% | SCHEDULE 13G |
| 2026-02-17 | 22nd Century Group | Anson Funds Management LP | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Dbv Technologies S.A. | MPM BioImpact LLC | 9.9% | SCHEDULE 13G |
| 2026-02-18 | CDT Equity Inc. | Ascent Partners Fund LLC | 9.9% | SCHEDULE 13G |
| 2026-02-19 | Q32 Bio Inc. | Point72 Asset Management, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-19 | La Rosa Holdings Corp. | SZOP Opportunities I LLC | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Worksport Ltd. | Armistice Capital, LLC | 9.84% | SCHEDULE 13G |
| 2026-02-17 | Texas Ventures Acquisition III Corp | Anson Funds Management LP | 9.8% | SCHEDULE 13G |
| 2026-02-17 | Verses AI Inc. | Sorbie Bornholm LP | 9.8% | SCHEDULE 13G |
| 2026-02-17 | Verses AI Inc. | Sorbie Investments Llp | 9.8% | SCHEDULE 13G |
| 2026-02-20 | Ascent Solar Technologies, Inc. | Ryan Taylor | 9.8% | SCHEDULE 13G |
| 2026-02-17 | Palatin Technologies Inc | Driehaus Capital Management LLC | 9.79% | SCHEDULE 13G |
| 2026-02-17 | Babcock & Wilcox Enterprises, Inc. | Hood River Capital Management LLC | 9.58% | SCHEDULE 13G |
| 2026-02-17 | Quoin Pharmaceuticals Ltd. | Woodline Partners LP | 9.5% | SCHEDULE 13G |
| 2026-02-17 | TIC Solutions, Inc. | Alyeska Investment Group, L.P. | 9.47% | SCHEDULE 13G |
| 2026-02-17 | GigCapital7 Corp. | Highbridge Capital Management, LLC | 9.4% | SCHEDULE 13G |
| 2026-02-17 | Sohu.com Ltd | Nomura Asset Management International Inc. | 9.4% | SCHEDULE 13G |
| 2026-02-17 | Blue Acquisition Corp. | Sona Asset Management (Us) LLC | 9.4% | SCHEDULE 13G |
| 2026-02-17 | Urban One, Inc. | Citadel Securities GP LLC | 9.4% | SCHEDULE 13G |
| 2026-02-17 | Foresight Financial Group Inc. | AllianceBernstein L.P. | 9.4% | SCHEDULE 13G |
| 2026-02-17 | Wealthfront Corp | DAG Ventures Management IV, LLC | 9.4% | SCHEDULE 13G |
| 2026-02-17 | ADC Therapeutics SA | TCG Crossover GP II, LLC | 9.2% | SCHEDULE 13G |
| 2026-02-17 | Cartesian Growth Corp III | Fort Baker Capital Management LP | 9.2% | SCHEDULE 13G |
| 2026-02-19 | Energous Corp | MYDA Advisors LLC | 9.19% | SCHEDULE 13G |
| 2026-02-17 | Andersen Group Inc. | J. Goldman & Co LP | 9.17% | SCHEDULE 13G |
| 2026-02-17 | TuHURA Biosciences, Inc. | Highbridge Capital Management, LLC | 9.1% | SCHEDULE 13G |
| 2026-02-20 | United Acquisition Corp. I | RP Investment Advisors LP | 9.1% | SCHEDULE 13G |
| 2026-02-17 | SR Bancorp Inc | Somerset Regal Bank Employee Stock Ownership Plan Trust | 9% | SCHEDULE 13G |
| 2026-02-17 | New Fortress Energy Inc. | Energy Transition Holdings LLC | 9% | SCHEDULE 13G |
| 2026-02-17 | Grupo Aeromexico, S.A.B. de C.V. | Silver Point Capital, L.P. | 9% | SCHEDULE 13G |
| 2026-02-17 | Better Home & Finance Holding Company | Frontier Capital Management Co.,LLC | 8.91% | SCHEDULE 13G |
| 2026-02-17 | FB Bancorp Inc | Fidelity Bank Employee Stock Ownership Plan Trust | 8.8% | SCHEDULE 13G |
| 2026-02-17 | Connect Biopharma Holdings Ltd | Ikarian Capital, LLC | 8.8% | SCHEDULE 13G |
| 2026-02-17 | Pelican Acquisition Corp | Decagon Asset Management LLP | 8.66% | SCHEDULE 13G |
| 2026-02-20 | Q32 Bio Inc. | Opaleye Management Inc. | 8.65% | SCHEDULE 13G |
| 2026-02-17 | Crown Reserve Acquisition Corp. I | Magnetar Financial LLC | 8.6% | SCHEDULE 13G |
| 2026-02-17 | New America Acquisition I Corp. | Anson Funds Management LP | 8.6% | SCHEDULE 13G |
| 2026-02-17 | Cardinal Infrastructure Group Inc | Schonfeld Strategic Advisors LLC | 8.6% | SCHEDULE 13G |
| 2026-02-17 | Insight Digital Partners II | Polar Asset Management Partners Inc. | 8.6% | SCHEDULE 13G |
| 2026-02-17 | ZOOZ Strategy Ltd. | Newtyn Management, LLC | 8.6% | SCHEDULE 13G |
| 2026-02-17 | Bain Capital GSS Investment Corp. | Empyrean Capital Partners, LP | 8.5% | SCHEDULE 13G |
| 2026-02-18 | Paramount Gold Nevada Corp. | Yuan Fangjian | 8.5% | SCHEDULE 13G |
| 2026-02-17 | Pasithea Therapeutics Corp. | Ameriprise Financial, Inc. | 8.4% | SCHEDULE 13G |
| 2026-02-17 | Churchill Capital Corp XI | Empyrean Capital Partners, LP | 8.35% | SCHEDULE 13G |
| 2026-02-17 | Fifth District Bancorp Inc | Fifth District Savings Bank Employee Stock Ownership Plan Trust | 8.3% | SCHEDULE 13G |
| 2026-02-17 | ARKO Corp. | CIBC Private Wealth Group LLC | 8.3% | SCHEDULE 13G |
| 2026-02-18 | ARKO Petroleum Corp. | CIBC Private Wealth Group LLC | 8.3% | SCHEDULE 13G |
| 2026-02-17 | BlackRock MuniYield PA Quality | Rivernorth Capital Management, LLC | 8.24% | SCHEDULE 13G |
| 2026-02-17 | TON Strategy Co | Aristeia Capital, L.L.C. | 8.21% | SCHEDULE 13G |
| 2026-02-17 | Equity Lifestyle Properties, Inc. | T. Rowe Price Associates, Inc. | 8.2% | SCHEDULE 13G |
| 2026-02-17 | Morgan Stanley India Investment Fund, Inc. | Lazard Asset Management LLC | 8.2% | SCHEDULE 13G |
| 2026-02-17 | 4d Molecular Therapeutics, Inc. | Janus Henderson Group Plc | 8.1% | SCHEDULE 13G |
| 2026-02-20 | Cineverse Corp. | Corsair Capital Management, L.P. | 8.1% | SCHEDULE 13G |
| 2026-02-17 | Rice Acquisition Corp 3 | Oaktree Capital Management, L.P. | 8.02% | SCHEDULE 13G |
| 2026-02-17 | Fast Track Group | LOW Jiayi | 8.02% | SCHEDULE 13G |
| 2026-02-19 | SLR Investment Corp | Thornburg Investment Management | 8.01% | SCHEDULE 13G |
| 2026-02-17 | Alto Neuroscience, Inc. | Vestal Point Capital, LP | 8% | SCHEDULE 13G |
| 2026-02-17 | Silvia, Inc. | Anson Funds Management LP | 8% | SCHEDULE 13G |
| 2026-02-17 | People Inc (Formerly IAC INC.) | Aristeia Capital, L.L.C. | 7.96% | SCHEDULE 13G |
| 2026-02-17 | Bel Fuse Inc-Cl B | T. Rowe Price Associates, Inc. | 7.9% | SCHEDULE 13G |
| 2026-02-17 | Merlin, Inc. | Highbridge Capital Management, LLC | 7.9% | SCHEDULE 13G |
| 2026-02-17 | Imax Corp | Nomura Asset Management International Inc. | 7.9% | SCHEDULE 13G |
| 2026-02-17 | Social Commerce Partners Corp | Magnetar Financial LLC | 7.9% | SCHEDULE 13G |
| 2026-02-17 | OnKure Therapeutics, Inc. | ADAR1 Capital Management, LLC | 7.9% | SCHEDULE 13G |
| 2026-02-17 | Contineum Therapeutics, Inc. | Janus Henderson Group Plc | 7.9% | SCHEDULE 13G |
| 2026-02-18 | OKYO Pharma Ltd | Point72 Asset Management, L.P. | 7.9% | SCHEDULE 13G |
| 2026-02-17 | Lion Group Holding Ltd | Marex Financial | 7.8% | SCHEDULE 13G |
| 2026-02-17 | Ultra Clean Holdings Inc | Frontier Capital Management Co.,LLC | 7.73% | SCHEDULE 13G |
| 2026-02-17 | Ribbon Acquisition Corp | Rivernorth Capital Management, LLC | 7.66% | SCHEDULE 13G |
| 2026-02-17 | Sable Offshore Corp. | Alyeska Investment Group, L.P. | 7.65% | SCHEDULE 13G |
| 2026-02-17 | Shoals Technologies Group -A | T. Rowe Price Associates, Inc. | 7.6% | SCHEDULE 13G |
| 2026-02-17 | Hennessy Capital Investment Corp. Vii | Highbridge Capital Management, LLC | 7.6% | SCHEDULE 13G |
| 2026-02-17 | Contineum Therapeutics, Inc. | Balyasny Asset Management L.P. | 7.6% | SCHEDULE 13G |
| 2026-02-18 | Sutro Biopharma, Inc. | Bvf Partners L P | 7.6% | SCHEDULE 13G |
| 2026-02-17 | Kestra Medical Technologies | T. Rowe Price Associates, Inc. | 7.5% | SCHEDULE 13G |
| 2026-02-17 | Solid Biosciences Inc. | Vestal Point Capital, LP | 7.5% | SCHEDULE 13G |
| 2026-02-17 | Damora Therapeutics Inc | Jain Global LLC | 7.5% | SCHEDULE 13G |
| 2026-02-18 | Proem Acquisition Corp I | Linden Advisors LP | 7.5% | SCHEDULE 13G |
| 2026-02-17 | Palvella Therapeutics, Inc. | First Light Asset Management, LLC | 7.49% | SCHEDULE 13G |
| 2026-02-17 | Opus Genetics, Inc. | Balyasny Asset Management L.P. | 7.41% | SCHEDULE 13G |
| 2026-02-17 | InspireMD, Inc. | Orbimed Advisors LLC | 7.4% | SCHEDULE 13G |
| 2026-02-17 | Blue Acquisition Corp. | LMR Partners LLP | 7.4% | SCHEDULE 13G |
| 2026-02-17 | Karbon Capital Partners Corp. | Empyrean Capital Partners, LP | 7.4% | SCHEDULE 13G |
| 2026-02-17 | Immix Biopharma, Inc. | Janus Henderson Group Plc | 7.4% | SCHEDULE 13G |
| 2026-02-17 | X4 Pharmaceuticals, Inc. | Saturn V Capital Management LP | 7.36% | SCHEDULE 13G |
| 2026-02-17 | XPLR Infrastructure, LP | Anchorage Capital Advisors, L.P. | 7.3% | SCHEDULE 13G |
| 2026-02-17 | BillionToOne, Inc. | Oguzhan Atay | 7.3% | SCHEDULE 13G |
| 2026-02-17 | Newbridge Acquisition Limited | Space Summit Capital LLC | 7.3% | SCHEDULE 13G |
| 2026-02-17 | Titan Mining Corporation | Alyeska Investment Group, L.P. | 7.28% | SCHEDULE 13G |
| 2026-02-17 | Satellogic Inc | Alyeska Investment Group, L.P. | 7.25% | SCHEDULE 13G |
| 2026-02-17 | Sotera Health Company | Sessa Capital GP, LLC | 7.23% | SCHEDULE 13G |
| 2026-02-17 | Cartesian Growth Corp III | Highbridge Capital Management, LLC | 7.2% | SCHEDULE 13G |
| 2026-02-17 | Castle Biosciences, Inc. | RTW Investments, LP | 7.2% | SCHEDULE 13G |
| 2026-02-17 | ACV Auctions Inc. | Atreides Management, LP | 7.2% | SCHEDULE 13G |
| 2026-02-17 | Cantor Equity Partners II Inc | Alyeska Investment Group, L.P. | 7.17% | SCHEDULE 13G |
| 2026-02-17 | ESS Tech, Inc. | Alyeska Investment Group, L.P. | 7.14% | SCHEDULE 13G |
| 2026-02-17 | ZoomInfo Technologies Inc. | Ahmet H. Okumus | 7.1% | SCHEDULE 13G |
| 2026-02-17 | Cardinal Infrastructure Group Inc | AllianceBernstein L.P. | 7.1% | SCHEDULE 13G |
| 2026-02-17 | MapLight Therapeutics, Inc. | Forbion Growth Opportunities Fund III Cooperatief U.A. | 7.1% | SCHEDULE 13G |
| 2026-02-17 | Personalis, Inc. | Ameriprise Financial, Inc. | 7.1% | SCHEDULE 13G |
| 2026-02-17 | Crane Harbor Acquisition Corp. | Polar Asset Management Partners Inc. | 7.1% | SCHEDULE 13G |
| 2026-02-18 | Regional Health Properties, Inc | Radoff Bradley Louis | 7.1% | SCHEDULE 13G |
| 2026-02-17 | Freenome, Inc. | Holocene Advisors, LP | 7.02% | SCHEDULE 13G |
| 2026-02-17 | Immix Biopharma, Inc. | Saturn V Capital Management LP | 6.97% | SCHEDULE 13G |
| 2026-02-17 | Quoin Pharmaceuticals Ltd. | ADAR1 Capital Management, LLC | 6.9% | SCHEDULE 13G |
| 2026-02-17 | Ovid Therapeutics Inc. | ADAR1 Capital Management, LLC | 6.9% | SCHEDULE 13G |
| 2026-02-17 | BillionToOne, Inc. | David Tsao | 6.9% | SCHEDULE 13G |
| 2026-02-17 | Jakks Pacific Inc | Gate City Capital Management, LLC | 6.9% | SCHEDULE 13G |
| 2026-02-17 | Navan, Inc. | Greenoaks Capital Partners LLC | 6.9% | SCHEDULE 13G |
| 2026-02-17 | Abrdn Japan Equity Fund, Inc. | Almitas Capital LLC | 6.9% | SCHEDULE 13G |
| 2026-02-17 | TGE Value Creative Solutions Corp. | Aristeia Capital, L.L.C. | 6.81% | SCHEDULE 13G |
| 2026-02-17 | Bitcoin Infrastructure Acquisition Corp Ltd | Aristeia Capital, L.L.C. | 6.81% | SCHEDULE 13G |
| 2026-02-18 | Beeline Holdings, Inc. | Sansar Capital Master Fund, L.P. | 6.81% | SCHEDULE 13G |
| 2026-02-17 | Jade Biosciences, Inc. | Bellevue Group AG | 6.8% | SCHEDULE 13G |
| 2026-02-17 | Rocky Brands Inc | AllianceBernstein L.P. | 6.8% | SCHEDULE 13G |
| 2026-02-17 | Imperial Petroleum Inc. | Anson Funds Management LP | 6.8% | SCHEDULE 13G |
| 2026-02-17 | Artius II Acquisition Inc. | HGC Investment Management Inc | 6.76% | SCHEDULE 13G |
| 2026-02-17 | Hennessy Capital Investment Corp. Vii | Lighthouse Investment Partners, LLC | 6.74% | SCHEDULE 13G |
| 2026-02-18 | SCE Trust V | General Motors Investment Management Corporation | 6.74% | SCHEDULE 13G |
| 2026-02-17 | Celcuity Inc. | Avoro Capital Advisors LLC | 6.72% | SCHEDULE 13G |
| 2026-02-17 | Kornit Digital Ltd. | Disciplined Growth Investors Inc | 6.7% | SCHEDULE 13G |
| 2026-02-17 | Wealthfront Corp | Meyer Malka | 6.7% | SCHEDULE 13G |
| 2026-02-17 | TIC Solutions, Inc. | Gates Capital Management, L.P. | 6.7% | SCHEDULE 13G |
| 2026-02-17 | Definium Therapeutics, Inc. | Driehaus Capital Management LLC | 6.64% | SCHEDULE 13G |
| 2026-02-17 | BEST SPAC I Acquisition Corp. | Rivernorth Capital Management, LLC | 6.64% | SCHEDULE 13G |
| 2026-02-17 | Westin Acquisition Corp | Shaolin Capital Management LLC | 6.62% | SCHEDULE 13G |
| 2026-02-18 | Ituran Location & Control Ltd | Yehuda Kahane | 6.62% | SCHEDULE 13G |
| 2026-02-17 | Globa Terra Acquisition Corporation | LMR Partners LLP | 6.6% | SCHEDULE 13G |
| 2026-02-17 | Roman DBDR Acquisition Corp. II | Fort Baker Capital Management LP | 6.6% | SCHEDULE 13G |
| 2026-02-19 | Spartacus Acquisition Corp. II | Harraden Circle Investments, LLC | 6.52% | SCHEDULE 13G |
| 2026-02-17 | Adicet Bio, Inc. | Woodline Partners LP | 6.5% | SCHEDULE 13G |
| 2026-02-17 | Enliven Therapeutics Inc | Vestal Point Capital, LP | 6.5% | SCHEDULE 13G |
| 2026-02-17 | Ww International, Inc. | Cooper Creek Partners Management LLC | 6.5% | SCHEDULE 13G |
| 2026-02-17 | Commercial Bancgroup Inc | T. Rowe Price Investment Management, Inc. | 6.5% | SCHEDULE 13G |
| 2026-02-18 | Bicycle Therapeutics plc | Armistice Capital, LLC | 6.48% | SCHEDULE 13G |
| 2026-02-17 | Churchill Capital Corp XI | Magnetar Financial LLC | 6.44% | SCHEDULE 13G |
| 2026-02-17 | Elme Communities | Highbridge Capital Management, LLC | 6.4% | SCHEDULE 13G |
| 2026-02-17 | Cava Group Inc | AllianceBernstein L.P. | 6.4% | SCHEDULE 13G |
| 2026-02-17 | Xperi Inc. | Clearline Capital LP | 6.4% | SCHEDULE 13G |
| 2026-02-20 | ARKO Petroleum Corp. | CUSHING ASSET MANAGEMENT, LP dba NXG INVESTMENT MANAGEMENT | 6.4% | SCHEDULE 13G |
| 2026-02-17 | Voyager Technologies, Inc. | Alyeska Investment Group, L.P. | 6.35% | SCHEDULE 13G |
| 2026-02-19 | Chimera Investment Corp | Thornburg Investment Management | 6.34% | SCHEDULE 13G |
| 2026-02-17 | Fortive Corp | T. Rowe Price Associates, Inc. | 6.3% | SCHEDULE 13G |
| 2026-02-17 | Keurig Dr Pepper Inc. | Harris Associates L P | 6.3% | SCHEDULE 13G |
| 2026-02-17 | Hyperliquid Strategies Inc. | D1 Capital Partners L.P. | 6.3% | SCHEDULE 13G |
| 2026-02-17 | DigitalBridge Group, Inc. | Pentwater Capital Management LP | 6.3% | SCHEDULE 13G |
| 2026-02-17 | Zai Lab Limited | RTW Investments, LP | 6.3% | SCHEDULE 13G |
| 2026-02-17 | Spyglass Pharma, Inc. | Srinivas Akkaraju | 6.3% | SCHEDULE 13G |
| 2026-02-17 | RLJ Lodging Trust | H/2 Credit Manager LP | 6.3% | SCHEDULE 13G |
| 2026-02-17 | BOXABL Inc. (formerly FG Merger II Corp.) | Rivernorth Capital Management, LLC | 6.24% | SCHEDULE 13G |
| 2026-02-19 | Ventyx Biosciences, Inc. | Glazer Capital, LLC | 6.23% | SCHEDULE 13G |
| 2026-02-17 | Equifax Inc. | Harris Associates L P | 6.2% | SCHEDULE 13G |
| 2026-02-17 | Zimmer Biomet Holdings, Inc. | Harris Associates L P | 6.2% | SCHEDULE 13G |
| 2026-02-17 | Odysseus (Cayman) Ltd | Highbridge Capital Management, LLC | 6.2% | SCHEDULE 13G |
| 2026-02-17 | Jade Biosciences, Inc. | Janus Henderson Group Plc | 6.2% | SCHEDULE 13G |
| 2026-02-17 | Enviri LLC | Newtyn Management, LLC | 6.2% | SCHEDULE 13G |
| 2026-02-17 | MapLight Therapeutics, Inc. | T. Rowe Price Investment Management, Inc. | 6.2% | SCHEDULE 13G |
| 2026-02-17 | Jackson Acquisition Co II | HGC Investment Management Inc | 6.19% | SCHEDULE 13G |
| 2026-02-19 | Forrester Research, Inc. | Portolan Capital Management, LLC | 6.12% | SCHEDULE 13G |
| 2026-02-17 | Alkermes Plc | Baker Bros. Advisors LP | 6.1% | SCHEDULE 13G |
| 2026-02-17 | Sound Financial Bancorp Inc | AllianceBernstein L.P. | 6.1% | SCHEDULE 13G |
| 2026-02-17 | Moonlake Immunotherapeutics | Cormorant Asset Management, LP | 6.1% | SCHEDULE 13G |
| 2026-02-17 | Velos Acquisition I Corp. f/k/a M3-Brigade Acquisition V Corp. | Polar Asset Management Partners Inc. | 6.1% | SCHEDULE 13G |
| 2026-02-17 | Apellis Pharmaceuticals, Inc. | RTW Investments, LP | 6.1% | SCHEDULE 13G |
| 2026-02-17 | Green Dot Corporation | No Street GP LP | 6.1% | SCHEDULE 13G |
| 2026-02-17 | Uniti Group Inc | T. Rowe Price Investment Management, Inc. | 6.1% | SCHEDULE 13G |
| 2026-02-19 | Lyft Inc | Millennium Management LLC | 6.1% | SCHEDULE 13G |
| 2026-02-18 | European Wax Center, Inc. | Hilary L. Shane | 6.01% | SCHEDULE 13G |
| 2026-02-17 | First Financial Bancorp | Nomura Asset Management International Inc. | 6% | SCHEDULE 13G |
| 2026-02-17 | Fortune Brands Innovations, Inc. | Orbis Investment Management Ltd | 6% | SCHEDULE 13G |
| 2026-02-17 | Ptc Therapeutics, Inc. | Janus Henderson Group Plc | 6% | SCHEDULE 13G |
| 2026-02-17 | Damora Therapeutics Inc | Venrock Healthcare Capital Partners III, L.P. | 6% | SCHEDULE 13G |
| 2026-02-17 | Activate Energy Acquisition | KRYGER CAPITAL Ltd | 6% | SCHEDULE 13G |
| 2026-02-17 | Sonoco Products Co | Fuller & Thaler Asset Management, Inc. | 5.98% | SCHEDULE 13G |
| 2026-02-17 | enGene Holdings Inc. | Cormorant Asset Management, LP | 5.97% | SCHEDULE 13G |
| 2026-02-17 | Nakamoto Inc. | Alyeska Investment Group, L.P. | 5.93% | SCHEDULE 13G |
| 2026-02-17 | TCW Direct Lending VIII LLC | First Trust Capital Management L.P. | 5.93% | SCHEDULE 13G |
| 2026-02-17 | Range Capital Acquisition Corp II | Magnetar Financial LLC | 5.91% | SCHEDULE 13G |
| 2026-02-17 | Willis Towers Watson Public Limited Company | Harris Associates L P | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Dayforce, Inc. | Pentwater Capital Management LP | 5.9% | SCHEDULE 13G |
| 2026-02-17 | AA Mission Acquisition Corp. II | Magnetar Financial LLC | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Bel Fuse Inc-Cl B | Janus Henderson Group Plc | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Mfs High Yield Municipal Trust | Almitas Capital LLC | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Bain Capital GSS Investment Corp. | Fort Baker Capital Management LP | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Veris Residential, Inc. | H/2 Credit Manager LP | 5.9% | SCHEDULE 13G |
| 2026-02-17 | PROCEPT BioRobotics Corp | T. Rowe Price Investment Management, Inc. | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Ryan Specialty Holdings, Inc. | T. Rowe Price Investment Management, Inc. | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Bicara Therapeutics Inc. | T. Rowe Price Investment Management, Inc. | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Fortuna Mining Corp | Global X Management CO LLC | 5.87% | SCHEDULE 13G |
| 2026-02-17 | Rithm Acquisition Corp. | Empyrean Capital Partners, LP | 5.87% | SCHEDULE 13G |
| 2026-02-19 | XFLH Capital Corp | Feis Equities LLC | 5.85% | SCHEDULE 13G |
| 2026-02-17 | Louisiana-Pacific Corp | Eminence Capital, LP | 5.8% | SCHEDULE 13G |
| 2026-02-17 | Gibraltar Industries Inc | AllianceBernstein L.P. | 5.8% | SCHEDULE 13G |
| 2026-02-17 | Solana Co | Polar Asset Management Partners Inc. | 5.8% | SCHEDULE 13G |
| 2026-02-17 | Eastern Bankshares Inc | T. Rowe Price Investment Management, Inc. | 5.8% | SCHEDULE 13G |
| 2026-02-17 | Arts Way Manufacturing Co Inc | Walther Larry M | 5.8% | SCHEDULE 13G |
| 2026-02-19 | Sable Offshore Corp. | FourWorld Capital Management LLC | 5.8% | SCHEDULE 13G |
| 2026-02-17 | Daedalus Special Acquisition Corp. | J. Goldman & Co LP | 5.79% | SCHEDULE 13G |
| 2026-02-17 | Invest Green Acquisition Corp | Magnetar Financial LLC | 5.79% | SCHEDULE 13G |
| 2026-02-17 | Spruce Biosciences, Inc. | Alyeska Investment Group, L.P. | 5.79% | SCHEDULE 13G |
| 2026-02-17 | Energy Fuels Inc | Global X Management CO LLC | 5.75% | SCHEDULE 13G |
| 2026-02-17 | Installed Building Products | T. Rowe Price Associates, Inc. | 5.7% | SCHEDULE 13G |
| 2026-02-17 | Atmus Filtration Technologies Inc | T. Rowe Price Associates, Inc. | 5.7% | SCHEDULE 13G |
| 2026-02-17 | Paycom Software, Inc. | Harris Associates L P | 5.7% | SCHEDULE 13G |
| 2026-02-17 | Adagio Medical Holdings, Inc. | ADAR1 Capital Management, LLC | 5.7% | SCHEDULE 13G |
| 2026-02-17 | IHS Holding Ltd | International Finance Corporation | 5.7% | SCHEDULE 13G |
| 2026-02-17 | BridgeBio Pharma, Inc. | Janus Henderson Group Plc | 5.7% | SCHEDULE 13G |
| 2026-02-17 | Kalaris Therapeutics, Inc. | RTW Investments, LP | 5.7% | SCHEDULE 13G |
| 2026-02-17 | Agriculture & Natural Solutions Acquisition Corp | Fort Baker Capital Management LP | 5.7% | SCHEDULE 13G |
| 2026-02-17 | Pioneer Floating Rate Fund, Inc. | Almitas Capital LLC | 5.7% | SCHEDULE 13G |
| 2026-02-17 | Perrigo Co Plc | Fuller & Thaler Asset Management, Inc. | 5.69% | SCHEDULE 13G |
| 2026-02-17 | Kornit Digital Ltd. | Granahan Investment Management LLC | 5.67% | SCHEDULE 13G |
| 2026-02-17 | FTAI Infrastructure Inc. | Frontier Capital Management Co.,LLC | 5.65% | SCHEDULE 13G |
| 2026-02-20 | D. Boral Acquisition I Corp. | Sculptor Capital LP | 5.65% | SCHEDULE 13G |
| 2026-02-17 | Ssr Mining Inc. | Global X Management CO LLC | 5.63% | SCHEDULE 13G |
| 2026-02-17 | Stellar Bancorp Inc | North Reef Capital Management LP | 5.62% | SCHEDULE 13G |
| 2026-02-17 | Park Dental Partners, Inc. | Swenson Nicholas John | 5.6% | SCHEDULE 13G |
| 2026-02-17 | Kaiser Aluminum Corp | Nomura Asset Management International Inc. | 5.6% | SCHEDULE 13G |
| 2026-02-17 | Climb Bio, Inc. | MPM BioImpact LLC | 5.6% | SCHEDULE 13G |
| 2026-02-19 | ProCap Acquisition Corp | RP Investment Advisors LP | 5.6% | SCHEDULE 13G |
| 2026-02-20 | Tyra Biosciences, Inc. | Dapice Joshua J. | 5.6% | SCHEDULE 13G |
| 2026-02-17 | Skyline Builders Group Holding Limited | Philadelphia Financial Management of San Francisco, LLC | 5.59% | SCHEDULE 13G |
| 2026-02-17 | Relmada Therapeutics, Inc. | Spruce Street Capital LP | 5.57% | SCHEDULE 13G |
| 2026-02-17 | StoneX Group Inc | T. Rowe Price Associates, Inc. | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Masco Corp | Harris Associates L P | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Artivion, Inc. | Nomura Asset Management International Inc. | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Surrozen, Inc. | Braidwell LP | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Bitcoin Infrastructure Acquisition Corp Ltd | LMR Partners LLP | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Rekor Systems, Inc. | Anson Funds Management LP | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Mfs Investment Grade Municipal Trust | Almitas Capital LLC | 5.5% | SCHEDULE 13G |
| 2026-02-17 | PPL Corp | T. Rowe Price Investment Management, Inc. | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Ingersoll-Rand Inc | T. Rowe Price Investment Management, Inc. | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Sportradar Group Ag-A | T. Rowe Price Investment Management, Inc. | 5.5% | SCHEDULE 13G |
| 2026-02-19 | Immunic, Inc. | Soleus Capital Master Fund, L.P. | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Blueport Acquisition Ltd | Shaolin Capital Management LLC | 5.49% | SCHEDULE 13G |
| 2026-02-17 | SuperX AI Technology Ltd | Anatole Investment Management Limited | 5.48% | SCHEDULE 13G |
| 2026-02-17 | Andersen Group Inc. | Driehaus Capital Management LLC | 5.44% | SCHEDULE 13G |
| 2026-02-17 | ITHAX Acquisition Corp III | Magnetar Financial LLC | 5.43% | SCHEDULE 13G |
| 2026-02-17 | ITHAX Acquisition Corp III | Aristeia Capital, L.L.C. | 5.43% | SCHEDULE 13G |
| 2026-02-17 | Texas Ventures Acquisition III Corp | J. Goldman & Co LP | 5.41% | SCHEDULE 13G |
| 2026-02-17 | Pebblebrook Hotel Trust | T. Rowe Price Associates, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Pebblebrook Hotel Trust | T. Rowe Price Associates, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Fifth Third Bancorp | T. Rowe Price Associates, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Pebblebrook Hotel Trust | T. Rowe Price Associates, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Soleno Therapeutics, Inc. | Avoro Capital Advisors LLC | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Crescent Biopharma, Inc. | Vestal Point Capital, LP | 5.4% | SCHEDULE 13G |
| 2026-02-17 | BOXABL Inc. (formerly FG Merger II Corp.) | Highbridge Capital Management, LLC | 5.4% | SCHEDULE 13G |
| 2026-02-17 | GigCapital8 Corp | Lynrock Lake LP | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Blue Ridge Bankshares, Inc. | Azora Capital LP | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Spruce Biosciences, Inc. | ADAR1 Capital Management, LLC | 5.4% | SCHEDULE 13G |
| 2026-02-17 | FTAI Infrastructure Inc. | AllianceBernstein L.P. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Newbridge Acquisition Limited | Shaolin Capital Management LLC | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Vermilion Energy Inc | Ameriprise Financial, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Quanex Building Products Corp | Ameriprise Financial, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Cardinal Infrastructure Group Inc | Ross Berner | 5.4% | SCHEDULE 13G |
| 2026-02-17 | New America Acquisition I Corp. | Weiss Asset Management LP | 5.4% | SCHEDULE 13G |
| 2026-02-17 | AN2 Therapeutics, Inc. | Almitas Capital LLC | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Churchill Capital Corp XI | Fort Baker Capital Management LP | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Pool Corp | T. Rowe Price Investment Management, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Booz Allen Hamilton Holdings | T. Rowe Price Investment Management, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-19 | Neumora Therapeutics, Inc. | Raymond Debbane | 5.4% | SCHEDULE 13G |
| 2026-02-20 | NETSTREIT Corp. | Millennium Management LLC | 5.4% | SCHEDULE 13G |
| 2026-02-20 | Spartacus Acquisition Corp. II | RP Investment Advisors LP | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Miluna Acquisition Corp | Aristeia Capital, L.L.C. | 5.38% | SCHEDULE 13G |
| 2026-02-17 | A2z Cust2mate Solutions Corp. | Alyeska Investment Group, L.P. | 5.38% | SCHEDULE 13G |
| 2026-02-17 | Energy Recovery, Inc. | Amundi | 5.38% | SCHEDULE 13G |
| 2026-02-17 | Teva Pharmaceutical Industries Ltd | Migdal Insurance & Financial Holdings Ltd | 5.37% | SCHEDULE 13G |
| 2026-02-17 | Cohen Circle Acquisition Corp. II | Lighthouse Investment Partners, LLC | 5.35% | SCHEDULE 13G |
| 2026-02-17 | Silicon Valley Acquisition Corp. | Magnetar Financial LLC | 5.33% | SCHEDULE 13G |
| 2026-02-17 | Garrett Motion Inc | Fuller & Thaler Asset Management, Inc. | 5.32% | SCHEDULE 13G |
| 2026-02-17 | K2 Capital Acquisition Corp. | Shaolin Capital Management LLC | 5.31% | SCHEDULE 13G |
| 2026-02-17 | Ivanhoe Electric Inc | Alyeska Investment Group, L.P. | 5.31% | SCHEDULE 13G |
| 2026-02-17 | Kura Sushi USA Inc. | Hood River Capital Management LLC | 5.31% | SCHEDULE 13G |
| 2026-02-17 | Malibu Boats, Inc. | Nomura Asset Management International Inc. | 5.3% | SCHEDULE 13G |
| 2026-02-17 | Bbb Foods Inc | Orbis Investment Management Ltd | 5.3% | SCHEDULE 13G |
| 2026-02-17 | GRAIL, Inc. | Baker Bros. Advisors LP | 5.3% | SCHEDULE 13G |
| 2026-02-17 | Verastem, Inc. | Armistice Capital, LLC | 5.3% | SCHEDULE 13G |
| 2026-02-17 | K2 Capital Acquisition Corp. | Linden Capital L.P. | 5.3% | SCHEDULE 13G |
| 2026-02-17 | Glaukos Corp | Janus Henderson Group Plc | 5.3% | SCHEDULE 13G |
| 2026-02-17 | Navan, Inc. | Ilan Twig | 5.3% | SCHEDULE 13G |
| 2026-02-18 | Genius Sports Ltd | Senvest Management, LLC | 5.3% | SCHEDULE 13G |
| 2026-02-18 | Cabaletta Bio Inc | Millennium Management LLC | 5.3% | SCHEDULE 13G |
| 2026-02-17 | Agios Pharmaceuticals, Inc. | Armistice Capital, LLC | 5.21% | SCHEDULE 13G |
| 2026-02-17 | Clean Harbors Inc | D1 Capital Partners L.P. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | Vail Resorts Inc | Oasis Management Co Ltd. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | Manhattan Associates Inc | AllianceBernstein L.P. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | Marathon Bancorp, Inc. | AllianceBernstein L.P. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | Strattec Security Corp | AllianceBernstein L.P. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | Uscb Financial Holdings Inc | AllianceBernstein L.P. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | Upstart Holdings, INC. | Jericho Capital Asset Management L.P. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | TETRA Technologies, Inc. | Ameriprise Financial, Inc. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | HA Sustainable Infrastructure Capital, Inc. | T. Rowe Price Investment Management, Inc. | 5.2% | SCHEDULE 13G |
| 2026-02-18 | Eikon Therapeutics Inc | Abu Dhabi Investment Authority | 5.2% | SCHEDULE 13G |
| 2026-02-17 | Zeta Global Holdings Corp | Contour Asset Management LLC | 5.15% | SCHEDULE 13G |
| 2026-02-17 | Lincoln Educational Services Corp | Alyeska Investment Group, L.P. | 5.14% | SCHEDULE 13G |
| 2026-02-17 | Tat Technologies Ltd | Migdal Insurance & Financial Holdings Ltd | 5.13% | SCHEDULE 13G |
| 2026-02-17 | Iron Horse Acquisition II Corp. | Magnetar Financial LLC | 5.11% | SCHEDULE 13G |
| 2026-02-17 | Warrior Met Coal Inc | T. Rowe Price Associates, Inc. | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Warrior Met Coal Inc | T. Rowe Price Associates, Inc. | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Warrior Met Coal Inc | T. Rowe Price Associates, Inc. | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Flutter Entertainment plc | Parvus Asset Management Jersey Limited | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Arcellx, Inc. | Vestal Point Capital, LP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Day One Biopharmaceuticals, Inc. | Vestal Point Capital, LP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Gitlab Inc. | Eminence Capital, LP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Alpha Cognition Inc. | Manchester Management Company, LLC | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Iron Horse Acquisition II Corp. | LMR Partners LLP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Range Capital Acquisition Corp II | LMR Partners LLP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Camtek Ltd. | Migdal Insurance & Financial Holdings Ltd | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Hess Midstream LP | Harvest Fund Advisors LLC | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Kazia Therapeutics Ltd | Ikarian Capital, LLC | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Cardinal Infrastructure Group Inc | Mark McKinney | 5.1% | SCHEDULE 13G |
| 2026-02-17 | DraftKings Inc. | Janus Henderson Group Plc | 5.1% | SCHEDULE 13G |
| 2026-02-17 | RadNet, Inc. | RTW Investments, LP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | American Public Education Inc | No Street GP LP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | UMH Properties, Inc. | T. Rowe Price Investment Management, Inc. | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Indivior Pharmaceuticals, Inc. | Fuller & Thaler Asset Management, Inc. | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Airsculpt Technologies, Inc. | Parian Ultreia LP | 5.1% | SCHEDULE 13G |
| 2026-02-19 | Alpha Cognition Inc. | Funicular Funds, LP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Definium Therapeutics, Inc. | Avoro Capital Advisors LLC | 5.08% | SCHEDULE 13G |
| 2026-02-17 | Restaurant Brands International Inc. | EdgePoint Investment Group Inc. | 5.08% | SCHEDULE 13G |
| 2026-02-19 | Psyence Biomedical Ltd. | Weiner Jeffrey David | 5.07% | SCHEDULE 13G |
| 2026-02-17 | Centurion Acquisition Corp. | HGC Investment Management Inc | 5.04% | SCHEDULE 13G |
| 2026-02-17 | Minerals Technologies Inc | Nomura Asset Management International Inc. | 5.03% | SCHEDULE 13G |
| 2026-02-17 | Rambus Inc | T. Rowe Price Associates, Inc. | 5% | SCHEDULE 13G |
| 2026-02-17 | BJs RESTAURANTS INC | Woodline Partners LP | 5% | SCHEDULE 13G |
| 2026-02-17 | Taysha Gene Therapies, Inc. | Vestal Point Capital, LP | 5% | SCHEDULE 13G |
| 2026-02-17 | Praxis Precision Medicines, Inc. | Orbis Investment Management Ltd | 5% | SCHEDULE 13G |
| 2026-02-17 | Network-1 Technologies, Inc. | Cannell Capital LLC | 5% | SCHEDULE 13G |
| 2026-02-17 | Fifth District Bancorp Inc | AllianceBernstein L.P. | 5% | SCHEDULE 13G |
| 2026-02-17 | Ormat Technologies, Inc. | Migdal Insurance & Financial Holdings Ltd | 5% | SCHEDULE 13G |
| 2026-02-17 | Brightstar Lottery PLC | Lazard Asset Management LLC | 5% | SCHEDULE 13G |
| 2026-02-19 | Power REIT | Bradley and Daytona Railway and Land Co. LLC | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.
